Literature DB >> 9396459

Intimal hyperplasia after balloon injury is attenuated by blocking selectins.

M K Barron1, R S Lake, A J Buda, A N Tenaglia.   

Abstract

BACKGROUND: Cell adhesion molecules facilitate the adherence of platelets and leukocytes to the vascular endothelium in response to injury. Restenosis after balloon angioplasty is thought to represent the response to vascular injury. The role of cell adhesion in this process is unclear. METHODS AND
RESULTS: This study was performed in New Zealand White rabbits that underwent balloon angioplasty of the iliac artery. Expression of the cell adhesion molecule E-selectin on endothelium was determined by immunohistochemistry and increased at 6 hours with a peak expression 24 to 48 hours after balloon injury, returning to baseline by 1 week. The expression of L-selectin on circulating leukocytes, measured by flow cytometry, was significantly increased at 48 hours, with return to baseline by 1 week. In seven animals, the selectins were blocked with an analogue of sialyl-Lewis(x) given as an I.V. bolus of 10 mg/kg followed by 2 mg x kg(-1) x h(-1) I.P. infusion for 7 days. After 4 weeks, compared with control animals, the study group had a larger lumen area (57.7 versus 44.7 mm2, P<.05), smaller intima area (9.0 versus 19.2 mm2, P<.01), smaller intima/media ratio (0.4 versus 1.0, P<.01), and a smaller percent area stenosis (15.6% versus 34.3%, P<.01).
CONCLUSIONS: The cell adhesion molecules E-selectin and L-selectin are expressed after balloon injury. Blockade of the selectins has a favorable effect on the response to vascular injury.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9396459     DOI: 10.1161/01.cir.96.10.3587

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Central role of RAGE-dependent neointimal expansion in arterial restenosis.

Authors:  Taichi Sakaguchi; Shi Fang Yan; Shi Du Yan; Dmitri Belov; Ling Ling Rong; Monica Sousa; Martin Andrassy; Steven P Marso; Stephan Duda; Bernd Arnold; Birgit Liliensiek; Peter P Nawroth; David M Stern; Ann Marie Schmidt; Yoshifumi Naka
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Decreased neointimal formation in Mac-1(-/-) mice reveals a role for inflammation in vascular repair after angioplasty.

Authors:  D I Simon; Z Dhen; P Seifert; E R Edelman; C M Ballantyne; C Rogers
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

3.  Chronic intrauterine hypoxia interferes with aortic development in the late gestation ovine fetus.

Authors:  Jennifer A Thompson; Bryan S Richardson; Robert Gagnon; Timothy R H Regnault
Journal:  J Physiol       Date:  2011-05-03       Impact factor: 5.182

4.  The innate immune system contributes to tissue-engineered vascular graft performance.

Authors:  Narutoshi Hibino; Dane Mejias; Nicholas Pietris; Ethan Dean; Tai Yi; Cameron Best; Toshiharu Shinoka; Christopher Breuer
Journal:  FASEB J       Date:  2015-02-20       Impact factor: 5.191

Review 5.  The mechanisms of coronary restenosis: insights from experimental models.

Authors:  G A Ferns; T Y Avades
Journal:  Int J Exp Pathol       Date:  2000-04       Impact factor: 1.925

6.  Serum concentrations of soluble P-selectin glycoprotein ligand-1 are increased in patients with systemic sclerosis: association with lower frequency of pulmonary fibrosis.

Authors:  K Yanaba; K Takehara; S Sato
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

7.  Cell selective cardiovascular biology of microsomal prostaglandin E synthase-1.

Authors:  Lihong Chen; Guangrui Yang; Xiufeng Xu; Gregory Grant; John A Lawson; Mohammad Bohlooly-Y; Garret A FitzGerald
Journal:  Circulation       Date:  2012-11-30       Impact factor: 29.690

8.  Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice.

Authors:  Soon Yew Tang; James Monslow; Leslie Todd; John Lawson; Ellen Puré; Garret A FitzGerald
Journal:  Circulation       Date:  2014-02-11       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.